Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of January 2024, with the report dated January 12, 2024. The filing serves to notify the SEC of a corporate event regarding the company's listing status on the Nasdaq stock exchange.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of regulatory compliance status rather than a financial statement.
Material Changes
The primary material change reported is that Icecure Medical Ltd. has regained compliance with the Nasdaq Minimum Closing Bid Price Rule. This status update was communicated via a press release issued on January 12, 2024, which is included as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, management commentary on future operations, or a discussion of risks and contingencies beyond the context of the Nasdaq compliance issue. The document focuses solely on the incorporation of the press release into the company's existing Registration Statements on Forms F-3 and S-8.
Investor Verification Checklist
- Verify the current Nasdaq listing status of Icecure Medical Ltd. to confirm continued compliance.
- Review the full text of the press release (Exhibit 99.1) for details on the specific bid price thresholds met.
- Check subsequent filings for any updated financial data, as this Form 6-K contains no financial metrics.